OAC
STOK icon

OMERS Administration Corp’s Stoke Therapeutics STOK Stock Holding History

OMERS Administration Corp’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Buy
+41,500
New +$1.36M 0.01% 595
2025
Q4 		– Sell
-12,100
Closed -$284K – 1317
2025
Q3 		$284K Buy
+12,100
New +$207K ﹤0.01% 896

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OMERS Administration Corp's STOK Position: Q1 2026 in Review

OMERS Administration Corp opened a new position in Stoke Therapeutics (STOK) in Q1 2026: 41,500 shares worth $1.35M. The stake represents 0.01% of the portfolio and ranks #595 among its holdings. This is a return to the name: OMERS Administration Corp previously reported a position in STOK as recently as Q3 2025.

OMERS Administration Corp first reported a position in STOK in Q3 2025 and has held it in 2 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • OMERS Administration Corp held 41,500 shares of Stoke Therapeutics worth $1.35M as of Q1 2026.
  • Stoke Therapeutics was a new OMERS Administration Corp position in Q1 2026.
  • Stoke Therapeutics made up 0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #595 holding.
  • OMERS Administration Corp first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.